NVIDIA Corporation (NVDA)
| Market Cap | 4.51T |
| Revenue (ttm) | 187.14B |
| Net Income (ttm) | 99.20B |
| Shares Out | 24.30B |
| EPS (ttm) | 4.04 |
| PE Ratio | 45.99 |
| Forward PE | 26.53 |
| Dividend | $0.04 (0.02%) |
| Ex-Dividend Date | Dec 4, 2025 |
| Volume | 157,993,097 |
| Open | 185.00 |
| Previous Close | 184.94 |
| Day's Range | 183.40 - 188.11 |
| 52-Week Range | 86.62 - 212.19 |
| Beta | 2.31 |
| Analysts | Strong Buy |
| Price Target | 253.26 (+36.3%) |
| Earnings Date | Feb 25, 2026 |
About NVDA
NVIDIA Corporation, a computing infrastructure company, provides graphics and compute and networking solutions in the United States, Singapore, Taiwan, China, Hong Kong, and internationally. The Compute & Networking segment includes its Data Centre accelerated computing platforms and artificial intelligence solutions and software; networking; automotive platforms and autonomous and electric vehicle solutions; Jetson for robotics and other embedded platforms; and DGX Cloud computing services. The Graphics segment offers GeForce GPUs for gaming a... [Read more]
Financial Performance
In 2024, NVIDIA's revenue was $130.50 billion, an increase of 114.20% compared to the previous year's $60.92 billion. Earnings were $72.88 billion, an increase of 144.89%.
Financial StatementsAnalyst Summary
According to 39 analysts, the average rating for NVDA stock is "Strong Buy." The 12-month stock price target is $253.26, which is an increase of 36.30% from the latest price.
News
US gives green light to Nvidia H200 chip exports to China
The Trump administration on Tuesday gave the green light to China-bound sales of Nvidia's second most powerful AI chips, putting in place a rule that will likely kickstart shipments of the H200 despit...
Nvidia is a buying opportunity as the stock has pulled back, says Wolfe's Chris Caso
Chris Caso, Wolfe Research senior analyst, joins 'The Exchange' to discuss Caso's thoughts on Nvidia, Google and much more.
Dan Ives on GOOGL & AAPL, NVDA AI Dominance, TSLA Robotaxi Rollout & IVES ETF
Dan Ives believes we're still in stage three of ten when it comes to the AI revolution. He talks about why Apple (AAPL) will "continue to bet on Google" to power its AI as Alphabet (GOOGL) hits all-ti...
Nvidia's stock was just named a top pick for a reason that might be surprising
The chip giant's stock has actually been an AI laggard lately, creating opportunity for investors.
China limits Nvidia chip purchases to special circumstances, Information reports
The Chinese government this week told some tech companies it would only approve their purchases of Nvidia's H200 AI chips under special circumstances, such as for university research, the Information ...
Mag Seven Outperformance Story Not Over, Morgan Stanley Says
Michael Zezas, deputy head of global research at Morgan Stanley, discusses the outlook for Magnificent Seven stocks and the performance of US mid- and small-caps. He speaks on Bloomberg Television.
Nvidia stock continues to slide: why investors remain cautious
Nvidia shares remained under pressure early Tuesday as investors weighed mixed signals surrounding the company's ability to sell its H200 artificial intelligence chips to Chinese customers, alongside ...
Nvidia Is Driving A 70% Cost Crash In Drug Discovery — Lilly Just Bet $1 Billion On It
The cost of drug discovery has always been time. Nvidia Corp (NASDAQ: NVDA) says it just crushed that cost by 70% — and Eli Lilly And Co (NYSE: LLY) just put $1 billion behind the claim.
'Big Short' investor Michael Burry explains why he's betting against Nvidia, not Meta or Microsoft
Michael Burry says he's short Nvidia as it's especially exposed to what he sees as an AI bubble. The "Big Short" investor said Meta, Alphabet, and Microsoft are less at risk if the bubble bursts.
Nvidia Stock Is Stuck. Why This Analyst Still Expects Gains.
Nvidia could sell up to two million chips to China this year but questions remain over when licenses will be approved.
Nvidia's Key Supplier ASML Enters Top Momentum Tier As Bernstein Forecasts 'Big Years' For Chip Giant
ASML Holding NV (NASDAQ: ASML) has officially broken into the upper echelon of market leaders, surging in its Benzinga Edge's momentum score.
Nvidia Quietly Undermining Tesla's Physical AI Story
As we enter early 2026, the competition for “physical AI” – the transformation from intelligence limited to screens to machines capable of moving, seeing, and acting in the real world – has become the...
NVIDIA Corporation (NVDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
NVIDIA Corporation (NVDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Nvidia says no upfront payment needed for its H200 chips
Nvidia does not require upfront payment for H200 chips, a spokesperson for the U.S. chipmaker said in a statement to Reuters on Tuesday.
Nvidia to Invest $1 Billion in AI Drug Lab With Eli Lilly
Nvidia plans to invest $1 billion over five years in a new laboratory with Eli Lilly & Co., in an effort to speed up the use of AI in the pharmaceutical industry. Denny Fish, portfolio manager on the ...
Eli Lilly CFO on $1 billion Nvidia investment
NVIDIA plans to invest $1 billion over five years in a new laboratory with Eli Lilly and Company, aiming to speed up the use of artificial intelligence in the pharmaceutical industry. Heres what Eli L...
Nvidia stock continues to crawl but analysts see strong upside ahead
Nvidia stock traded largely flat on Monday, showing little reaction to news of a major new partnership with Eli Lilly, as investors remained focused on the chipmaker's prospects in China and the broad...
Multiply Labs to Bring “Physical AI” Robotics Technology to Advanced Biomanufacturing With NVIDIA
SAN FRANCISCO--(BUSINESS WIRE)-- #MultiplyLabs--Multiply Labs, a leader in robotic biomanufacturing, today announced a landmark milestone in its mission to scale production of cell and gene therapies;...
Nvidia Partners With Eli Lilly on AI Drug Laboratory
Nvidia plans to invest $1 billion over five years in a new laboratory with Eli Lilly & Co., aiming to speed up the use of artificial intelligence in the pharmaceutical industry. Jessica Nix has more o...
EndoQuest to Bring AI-Powered Vision and Precision to Endoluminal Robotic Surgery with NVIDIA IGX Thor
HOUSTON--(BUSINESS WIRE)--EndoQuest Robotics, Inc., a pioneering leader in endoluminal robotic surgical technology, today announced new initiatives as part of their collaboration with NVIDIA to integr...
Nvidia, Eli Lilly to spend $1 billion over five years on joint research lab
Nvidia and U.S. pharma giant Eli Lilly will spend $1 billion building a new joint research lab in the San Francisco Bay area over five years which will use Nvidia's newest generation Vera Rubin AI chi...
Owkin Advances Frontier Model Development for Biological Artificial Super Intelligence, Accelerated by NVIDIA
SAN FRANCISCO & PARIS--(BUSINESS WIRE)--Owkin, an AI company on a mission to solve the complexity of biology, today announced a collaboration with NVIDIA to enhance OwkinZero, Owkin's biological large...
NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery in the Age of AI
Companies to Jointly Invest up to $1 Billion Over Five Years in Infrastructure and Research Companies to Jointly Invest up to $1 Billion Over Five Years in Infrastructure and Research
NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery
News Summary: Lilly and NVIDIA launch AI co-innovation lab to tackle drug discovery challenges. NVIDIA collaborates with Thermo Fisher to build autonomous lab infrastructure for scalable scientific di...